Skip to main content
logo
Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
6,734.00
-456.00 (-6.34%)
Nov 6, 2026, 11:30 AM JST

Chugai Pharmaceutical Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
382,305426,602540,202458,674222,169267,753
Short-Term Investments
486,690553,094456,143280,308280,938204,217
Cash & Short-Term Investments
868,995979,696996,345738,982503,107471,970
Cash Growth
-1.52%-1.67%34.83%46.88%6.60%24.65%
Accounts Receivable
418,900442,876334,256318,892512,538355,081
Other Receivables
602368961,4561,745928
Receivables
418,960443,112335,152320,348514,283356,009
Inventory
290,806276,848240,067273,480292,206208,838
Prepaid Expenses
-24,85523,01321,82718,77017,301
Other Current Assets
60,14316,24711,46611,7898,1719,543
Total Current Assets
1,638,9041,740,7581,606,0431,366,4261,336,5371,063,661
Property, Plant & Equipment
500,015479,481441,554420,701386,651352,107
Long-Term Investments
-105,51273,07361,08656,18544,663
Other Intangible Assets
58,90554,53917,86819,86025,14121,974
Long-Term Deferred Tax Assets
76,39888,30469,83564,47465,24456,287
Other Long-Term Assets
100,0981---2
Total Assets
2,374,3202,468,5952,208,3731,932,5471,869,7581,538,694

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
78,174127,24765,353112,468209,835152,266
Accrued Expenses
-53,59149,32444,62937,75134,421
Current Portion of Leases
-7,7736,3656,9756,4346,550
Current Income Taxes Payable
79,515125,721142,49971,573121,160108,293
Current Unearned Revenue
-3731317986
Other Current Liabilities
98,88496,70826,78552,54148,47125,806
Total Current Liabilities
256,573411,077290,357288,217423,730327,422
Long-Term Leases
-17,9374,5326,4807,6759,490
Pension & Post-Retirement Benefits
5,0774,2453,9353,1463,3112,945
Long-Term Deferred Tax Liabilities
5,2954,0155,0765,7877,0867,614
Other Long-Term Liabilities
18,8395,5892,9743,3373,5693,206
Total Liabilities
285,784442,863306,874306,967445,371350,677

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
73,20273,20273,20273,20273,20273,202
Additional Paid-In Capital
67,02770,51569,89669,35568,80668,223
Retained Earnings
1,914,8181,890,0421,746,9341,488,7381,293,3521,054,050
Comprehensive Income & Other
33,489-8,02711,467-5,715-10,973-7,458
Total Common Equity
2,088,5362,025,7321,901,4991,625,5801,424,3871,188,017
Shareholders' Equity
2,088,5362,025,7321,901,4991,625,5801,424,3871,188,017
Total Liabilities & Equity
2,374,3202,468,5952,208,3731,932,5471,869,7581,538,694

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-25,71010,89713,45514,10916,040
Net Cash (Debt)
868,995953,986985,448725,527488,998455,930
Net Cash Growth
-1.52%-3.19%35.83%48.37%7.25%24.12%
Net Cash Per Share
528.06579.67598.82440.92297.20277.12
Filing Date Shares Outstanding
1,6451,6461,6461,6451,6451,644
Total Common Shares Outstanding
1,6451,6461,6461,6451,6451,644
Working Capital
1,382,3311,329,6811,315,6861,078,209912,807736,239
Book Value Per Share
1269.391230.911155.56988.01865.88722.50
Tangible Book Value
2,029,6311,971,1931,883,6311,605,7201,399,2461,166,043
Tangible Book Value Per Share
1233.591197.771144.70975.94850.59709.13